QQ客服 官方微博 反馈留言

浏览/检索结果: 共4条，第1-4条 帮助 已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 Pharmacological characterization of hetrombopag, a novel orally active human thrombopoietin receptor agonist 期刊论文 JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2018, 卷号: 22, 期号: 11, 页码: 5367-5377 作者:  Xie, Chengying;  Zhao, Huajun;  Bao, Xubin;  Fu, Haoyu;  Lou, Liguang 收藏  |  浏览/下载：34/0  |  提交时间：2019/01/08 eltrombopag  hetrombopag  hollow-fibre assay  thrombopoietin  thrombopoietin receptor   Safety, Pharmacokinetics and Pharmacodynamics of Hetrombopag Olamine, a Novel TPO-R Agonist, in Healthy Individuals 期刊论文 BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2017, 卷号: 121, 期号: 5, 页码: 414-422 作者:  Zheng, Li;  Liang, Mao-zhi;  Zeng, Xiao-ling;  Li, Cai-zheng;  Zhang, Yi-fan 收藏  |  浏览/下载：30/0  |  提交时间：2019/01/08 Safety, Pharmacokinetics and Pharmacodynamics of Hetrombopag Olamine, a Novel TPO-R Agonist, in Healthy Subjects. 期刊论文 Basic & Clinical Pharmacology & Toxicology, 2017 作者:  Zheng L;  Liang MZ;  Zeng XL;  Li CZ;  Zhang YF 收藏  |  浏览/下载：3/0  |  提交时间：2019/02/25 Hetrombopag, a Thrombopoietin Receptor Agonist, Protects Cardiomyocyte Survival from Oxidative Stress Damage as an Enhancer of Stem Cells 期刊论文 CARDIOVASCULAR DRUGS AND THERAPY, 2016, 卷号: 30, 期号: 6, 页码: 567-577 作者:  Zhou, Nannan;  Wang, Jianchun;  Li, Xiaodong;  Zhao, Yong;  Sun, Yuanyuan 收藏  |  浏览/下载：2/0  |  提交时间：2019/12/16 Hetrombopag  TPO receptor agonists  HSC/HPCs  Cardiac myocyte viability  Oxidative stress  Cardiovascular disease